Duavive (2020-05-20)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Duavive Tablet
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| AH6679, X51932, DC8998, AN0290 | - Recalling Firm
- Pfizer Canada Inc.
- 17300 Trans-Canada Hwy.
- Kirkland
- H9J 2M5
- Ontario
- CANADA
- Marketing Authorization Holder
- Pfizer Canada Inc.
- 17300 Trans-Canada Hwy.
- Kirkland
- H9J 2M5
- Ontario
- CANADA
| Duavive Tablet | DIN 02432854 | Tablet (Immediate And Extended Release) | Bazedoxifene 20 mg |
The affected lots may not meet the specification for dissolution of bazedoxifene during the product shelf-life.